Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Pradere

Showing results (301-310 of 412) with videos related to

Pageof 42
Sort By:
European Urology Oncology|November 10, 2021
Diagnostic Accuracy of Novel Urinary Biomarker Tests in Non-muscle-invasive Bladder Cancer: A Systematic Review and Network Meta-analysisEkaterina Laukhtina, Sung Ryul Shim, Keiichiro Mori, et al.
Current Opinion in Urology|November 23, 2021
Features and management of men with pN1 cM0 prostate cancer after radical prostatectomy and lymphadenectomy: a systematic review of population-based evidenceCharles Laine, Giorgio Gandaglia, Massimo Valerio, et al.
European Urology Oncology|January 22, 2022
Corrigendum to "Diagnostic Accuracy of Novel Urinary Biomarker Tests in Non-muscle-invasive Bladder Cancer: A Systematic Review and Network Meta-analysis" [Eur Urol Oncol 2021;4:927-42]Ekaterina Laukhtina, Sung Ryul Shim, Keiichiro Mori, et al.
Annals of Surgical Oncology|March 29, 2022
Prognostic Role of Preoperative Vascular Cell Adhesion Molecule-1 Plasma Levels in Urothelial Carcinoma of the Bladder Treated With Radical CystectomyKeiichiro Mori, Victor M Schuettfort, Satoshi Katayama, et al.
Molecular Carcinogenesis|September 29, 2021
Preoperative plasma level of endoglin as a predictor for disease outcomes after radical cystectomy for nonmetastatic urothelial carcinoma of the bladderEkaterina Laukhtina, Victor M Schuettfort, David D'Andrea, et al.
BMC Medicine|June 24, 2024
Global burden, risk factors, and temporal trends of ureteral cancer: a comprehensive analysis of cancer registriesJunjie Huang, Wing Sze Pang, Yat Ching Fung, et al.
Urologic Oncology|July 16, 2021
Incidence, risk factors and outcomes of urethral recurrence after radical cystectomy for bladder cancer: A systematic review and meta-analysisEkaterina Laukhtina, Keiichiro Mori, David D Andrea, et al.
Cancer Immunology, Immunotherapy : CII|February 16, 2021
Prognostic role of the systemic immune-inflammation index in upper tract urothelial carcinoma treated with radical nephroureterectomy: results from a large multicenter international collaborationKeiichiro Mori, Irene Resch, Noriyoshi Miura, et al.
European Urology Open Science|May 9, 2022
Comparative Outcomes of Primary Versus Recurrent High-risk Non-muscle-invasive and Primary Versus Secondary Muscle-invasive Bladder Cancer After Radical Cystectomy: Results from a Retrospective Multicenter StudyNico C Grossmann, Pawel Rajwa, Fahad Quhal, et al.
European Urology|November 9, 2023
The Efficacy and Safety of Metastasis-directed Therapy in Patients with Prostate Cancer: A Systematic Review and Meta-analysis of Prospective StudiesMarcin Miszczyk, Pawel Rajwa, Takafumi Yanagisawa, et al.
Pageof 42

Showing results (301-310 of 412) with videos related to

Sort By:
Pageof 42
European Urology Oncology|November 10, 2021
Diagnostic Accuracy of Novel Urinary Biomarker Tests in Non-muscle-invasive Bladder Cancer: A Systematic Review and Network Meta-analysisEkaterina Laukhtina, Sung Ryul Shim, Keiichiro Mori, et al.
Current Opinion in Urology|November 23, 2021
Features and management of men with pN1 cM0 prostate cancer after radical prostatectomy and lymphadenectomy: a systematic review of population-based evidenceCharles Laine, Giorgio Gandaglia, Massimo Valerio, et al.
European Urology Oncology|January 22, 2022
Corrigendum to "Diagnostic Accuracy of Novel Urinary Biomarker Tests in Non-muscle-invasive Bladder Cancer: A Systematic Review and Network Meta-analysis" [Eur Urol Oncol 2021;4:927-42]Ekaterina Laukhtina, Sung Ryul Shim, Keiichiro Mori, et al.
Annals of Surgical Oncology|March 29, 2022
Prognostic Role of Preoperative Vascular Cell Adhesion Molecule-1 Plasma Levels in Urothelial Carcinoma of the Bladder Treated With Radical CystectomyKeiichiro Mori, Victor M Schuettfort, Satoshi Katayama, et al.
Molecular Carcinogenesis|September 29, 2021
Preoperative plasma level of endoglin as a predictor for disease outcomes after radical cystectomy for nonmetastatic urothelial carcinoma of the bladderEkaterina Laukhtina, Victor M Schuettfort, David D'Andrea, et al.
BMC Medicine|June 24, 2024
Global burden, risk factors, and temporal trends of ureteral cancer: a comprehensive analysis of cancer registriesJunjie Huang, Wing Sze Pang, Yat Ching Fung, et al.
Urologic Oncology|July 16, 2021
Incidence, risk factors and outcomes of urethral recurrence after radical cystectomy for bladder cancer: A systematic review and meta-analysisEkaterina Laukhtina, Keiichiro Mori, David D Andrea, et al.
Cancer Immunology, Immunotherapy : CII|February 16, 2021
Prognostic role of the systemic immune-inflammation index in upper tract urothelial carcinoma treated with radical nephroureterectomy: results from a large multicenter international collaborationKeiichiro Mori, Irene Resch, Noriyoshi Miura, et al.
European Urology Open Science|May 9, 2022
Comparative Outcomes of Primary Versus Recurrent High-risk Non-muscle-invasive and Primary Versus Secondary Muscle-invasive Bladder Cancer After Radical Cystectomy: Results from a Retrospective Multicenter StudyNico C Grossmann, Pawel Rajwa, Fahad Quhal, et al.
European Urology|November 9, 2023
The Efficacy and Safety of Metastasis-directed Therapy in Patients with Prostate Cancer: A Systematic Review and Meta-analysis of Prospective StudiesMarcin Miszczyk, Pawel Rajwa, Takafumi Yanagisawa, et al.
Pageof 42